Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.

Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for […]

Continue Reading

Digital Transformation Of Emerging Markets Could Mean Continued Opportunity For Newly NASDAQ Listed Japanese Company

Previously published on Benzinga HeartCore Enterprises Inc. (NASDAQ: HTCR) is a software-as-a-service (SaaS) solutions provider and leading development company in the enterprise business sector. In February, the company was uplisted to the Nasdaq Stock Exchange and rang the opening bell.  Last June, Founder and CEO Sumitaka Kanno was honored with the Top 100 Tech Innovators & Influencers Award at InterCon Las Vegas for his significant and tangible contributions to the world of technology. HeartCore already […]

Continue Reading

CXM Software Creator Just Uplisted Last Month — Here’s What You May Want To Know

heartcore 0 1 HeartCore Enterprises Inc. (NASDAQ: HTCR) is a software-as-a-service (SaaS) solutions company that says it believes in making its customers and employees happy. 

Previously Published on Benzinga HeartCore Enterprises Inc. (NASDAQ: HTCR) is a software-as-a-service (SaaS) solutions company that says it believes in making its customers and employees happy.  The focus of many of its products is based on knowing the customer. When listing the three steps for successful digital marketing, HeartCore states that it emphasizes the need to know your customers, support them and keep them engaged.  Who Is HeartCore Enterprises, Anyway? Headquartered in Tokyo, Japan, with offices […]

Continue Reading

Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships

Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships --- smart glasses, wearables, augmented reality, virtual reality, benzinga, jessica abraham

Previously Published to Benzinga It’s a new year, and 2022 may just become the Year of the Meta with virtual reality (VR), augmented reality (AR), and extended reality (XR) around every corner.  Vuzix Corp. (NASDAQ: VUZI) is arguably no exception, leaving 2021 with a bang and entering the new year fresh-faced and making moves. The company is a leading supplier of smart glasses and AR technologies, developing innovative products primarily focused on enterprise markets. This includes […]

Continue Reading